Background: Sharing of tissue samples for research and disease surveillance purposes has become increasingly important. While it is clear that this is an area of intense, international controversy, there is an absence of data about what researchers themselves and those involved in the transfer of samples think about these issues, particularly in developing countries. Methods: A survey was carried out in a number of Asian countries and in Egypt to explore what researchers and others involved in research, storage and transfer (...) of human tissue samples thought about some of the issues related to sharing of such samples. Results: The results demonstrated broad agreement with the positions taken by developing countries in the current debate, favoring quite severe restrictions on the use of samples by developed countries. Conclusions: It is recommended that an international agreement is developed on what conditions should be attached to any sharing of human tissue samples across borders. (shrink)

American health care reformers face a number of ethical issues, including familiar debates over the merits of a single-payer system and publicly provided universal health insurance. No matter how these debates are resolved, a further ethical question must be addressed. Both universal coverage and a single-payer system are compatible with permitting some patients to pay more for faster, better, or more health care choices. Should the United States continue to have a two-tier health care system in which wealth grants some (...) patients access to medical services that others with the same needs cannot obtain? Critical evaluation of both principled objections to inequalities and practical objections to anticipated social and medical consequences of a two-tier health care system are needed. (shrink)

Although research findings have always been subject to abuse, scientific advances and recent events have increased concern about the perils of some biomedical knowledge. The Council on Ethical and Judicial Affairs addresses this potential in its guidelines for physician–researchers. The guidelines do not advance many novel ideas or provide substantive guidance for PRs. Advocacy for professionalism, weighing costs and benefits, and balanced oversight are uncontroversial and have been proposed before. The difficult task is to define what they require, and here (...) the guidelines are vague. We discuss critically two issues that deserve careful attention. (shrink)

Volume 20, Issue 8, August 2020, Page 119-120.

Volume 20, Issue 8, August 2020, Page 125-127.